Prolonged aPTT Before Surgery: Factor Deficiency, Inhibitor, or Lupus Anticoagulant?
34-year-old woman is seen before elective knee surgery. She has no bleeding history, but her aPTT is 58 seconds (reference 25–35) and PT is 12.1 seconds (reference 11–13.5). Platelet count is 180 × 10^9/L, fibrinogen is normal, and factor VIII activity is 62%. A 1:1 mixing study with normal pooled plasma gives an immediate aPTT of 42 seconds and a 2-hour incubated aPTT of 50 seconds; the reference aPTT for the same method is 32 seconds. She has a history of two first-trimester pregnancy losses and one unprovoked calf DVT at age 29. She takes no anticoagulants. The surgeon asks whether she has a bleeding disorder and whether fresh frozen plasma should be given preoperatively.
1. Interpret the mixing study. Does it indicate a factor deficiency, a specific inhibitor, or a lupus anticoagulant?
Read the worked answer
A factor deficiency should correct both immediately and after incubation because normal plasma supplies the missing factor. Here, the immediate aPTT partially corrects from 58 to 42 seconds but remains above the reference of 32 seconds, and the incubated aPTT does not correct at 50 seconds. This pattern suggests an inhibitor rather than a simple factor deficiency. A specific factor inhibitor is possible, but factor VIII activity is 62%, which argues against a factor VIII inhibitor. The time-dependent, incomplete correction is typical of a lupus anticoagulant, especially in a woman with pregnancy loss and prior unprovoked thrombosis. The normal PT also fits a lupus anticoagulant, which often affects phospholipid-dependent aPTT reagents more than PT. The mixing study is supportive but not diagnostic; confirmatory phospholipid-dependent testing is required.
2. What confirmatory testing should be done, and how do the results influence management?
Read the worked answer
Confirm with a dilute Russell viper venom time (dRVVT) screen and confirmatory platelet neutralization, and test anticardiolipin and anti-beta2-glycoprotein I antibodies. Repeat positive results after at least 12 weeks to classify antiphospholipid syndrome. If the lupus anticoagulant is confirmed, fresh frozen plasma is not indicated because the prolongation is not due to a missing factor and FFP will not correct the inhibitor; it may add volume without benefit. Her bleeding risk is not increased by the lupus anticoagulant itself, but her thrombotic history matters. Perioperative management should focus on venous thromboembolism prophylaxis and hematology input rather than prophylactic FFP. If a specific factor inhibitor were found instead, management would differ and factor replacement or bypassing agents might be needed.
3. Why is a prolonged aPTT with a normal PT not enough to diagnose a bleeding disorder?
Read the worked answer
A prolonged aPTT can result from factor deficiency, a specific inhibitor, a lupus anticoagulant, factor XII deficiency, or preanalytical problems such as an underfilled citrate tube. Factor XII deficiency markedly prolongs the aPTT but does not cause bleeding. Lupus anticoagulants prolong phospholipid-dependent tests in vitro but are associated with thrombosis, not bleeding. The patient’s personal and family bleeding history, the mixing study pattern, and specific factor assays determine the clinical significance. In this case, the absence of bleeding and the history of thrombosis point away from a bleeding disorder and toward an antiphospholipid antibody. The judgment is to confirm the inhibitor before acting, and not to treat a laboratory number with FFP when the underlying mechanism is not a factor deficiency.